Part-Time

Aseptic Cleaning Technician

Posted on 5/9/2026

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

Compensation Overview

$19.54 - $21.98/hr

+ Annual Performance Bonus + Pay Differential (10%)

Bloomingdale, IL, USA + 1 more

More locations: San Diego, CA, USA

In Person

On-site role; part-time with evening shifts in San Diego, CA and Roselle, IL.

Category
Cleaning & Custodial Services (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • High School Diploma or GED preferred.
  • 0-1 year of aseptic gowning, cleanroom, and/or cGMP experience.
  • Ability to learn proper cleanroom behavior and aseptic technique concepts.
  • Able to learn use of equipment documentation as required, including logbooks and binders.
  • Basic understanding of solution chemistry needed to properly mix chemicals is preferred.
  • Comprehension of QAD, ACE, LIMS, and RAM is preferred.
  • Familiarity with basic Microsoft Office programs such as Word, Excel, and Outlook is preferred.
  • Ability to work independently or as team player.
  • Detail Oriented.
  • Ability to receive Aseptic Gowning Qualification will be required.
Responsibilities
  • Perform sanitization duties in the cleanroom while aseptically gowned.
  • Properly formulate sterile/nonsterile disinfectant cleaning solutions in Drug Product areas.
  • Record and complete documentation as needed, including forms and logbooks in compliance with cGMP guidelines.
  • Participates in regularly scheduled group trainings and departmental meetings.
  • Group meetings.
  • Internal investigations (Deviations, Safety Audits, Internal Audits).
  • Maintain facility and equipment through routine cleaning and sanitization in designated areas within the cleanroom as indicated in standard operating procedures.
  • Operate general production equipment such as autoclaves.
  • Formulate cleaning solutions and sanitize sterile/nonsterile Drug Product areas.
  • Collect all used disinfectant solution waste and place in the appropriate disposal unit.
  • Regular and reliable attendance on a full-time basis [or in accordance with posted schedule].
  • Responsible for exhibiting professional behavior with both internal and external business associates that reflects positively on the company and is consistent with the company’s policies and practices.
  • Embodies PCI Pharma Service’s cultural values and aligns daily actions with department goals and company culture.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at PCI Pharma Services who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.